Plunkett Research Online: CEL-SCI Corporation

CEL-SCI CORPORATION (CVM:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

CEL-SCI Corporation researches and develops immunotherapy products for the treatment of cancer and infectious diseases. Its flagship product, Multikine (leukocyte interleukin, injection), is one of the first of a new class of cancer immunotherapy drugs. It simulates the activities of a healthy per.....



CEL-SCI Corporation
Ticker: CVM
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 703 506-9460
Fax: 703 506-9471
Address: 8229 Boone Boulevard
Suite 802
Vienna, VA 22182 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Cancer & Infectious Disease
Vaccines
Immunotherapy
ContactsDescription
Geert KerstenCEO/CFO/Chief Accounting Officer/Director/Treasurer
Eyal TalorChief Scientific Officer
See More
CEL-SCI Corporation researches and develops immunotherapy products for the treatment of cancer and infectious diseases. Its flagship product, Multikine (leukocyte interleukin, injection), is one of the first of a new class of cancer immunotherapy drugs. It simulates the activities of a healthy per.....See More See More

Auditor: BDO USA, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Multikine
Ligand Epitope Antigen Presentations System
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors:

Employees of the company receive benefits including medical, dental, vision and long-term disability coverage; flexible spending accounts; and a 401(k).